DATPT

CAS No. 2891582-75-3

DATPT( —— )

Catalog No. M36598 CAS No. 2891582-75-3

DATPT is a small molecule 12WLVSKF17 peptide mimetic molecule.DATPT inhibits SNX9-p47phox interactions and inhibits the production of reactive oxygen species and inflammatory cytokines.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 242 In Stock
10MG 392 In Stock
25MG 787 In Stock
50MG 1237 In Stock
100MG 1972 In Stock
200MG Get Quote In Stock
500MG 3962 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DATPT
  • Note
    Research use only, not for human use.
  • Brief Description
    DATPT is a small molecule 12WLVSKF17 peptide mimetic molecule.DATPT inhibits SNX9-p47phox interactions and inhibits the production of reactive oxygen species and inflammatory cytokines.
  • Description
    DATPT is a small molecule 12WLVSKF17 peptide mimetic molecule.DATPT inhibits SNX9-p47phox interactions and inhibits the production of reactive oxygen species and inflammatory cytokines.DATPT has anti-inflammatory and antimicrobial activity and acts by decreasing ATP production.DATPT is a potential compound for the treatment of sepsis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Reactive Oxygen Species | Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2891582-75-3
  • Formula Weight
    495.06
  • Molecular Formula
    C24H39ClN6O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.N=1C(=NC(=NC1NCC2OCCC2)C=3C=CC(=CC3)C(C)(C)C)NCCOCCOCCN
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 3,3-Di-O-methylellag...

    3,3'-Di-O-methylellagic acid 4'-glucoside is a natural product.

  • Steroidogenesis-Acti...

    Steroidogenesis-Activator Polypeptide (rat)

  • IACS-52825

    IACS-52825 is a selective and potent dual leucine zipper kinase (DLK) inhibitor that reverses para-mechanical aberrant pain in a CIPN mouse model for the study of neurological disorders.